Skip Nav Destination
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers
Survival benefit with imatinib mesylate versus interferon-α–based regimens in newly diagnosed chronic-phase chronic myelogenous leukemia
The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera
A novel fibrinogen variant (fibrinogen Seoul II; AαGln328Pro) characterized by impaired fibrin α-chain cross-linking
Compound heterozygosity of novel missense mutations in the gamma-glutamyl-carboxylase gene causes hereditary combined vitamin K–dependent coagulation factor deficiency
Frequent antibody production against RARα in both APL mice and patients
Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia
The molecular classification of multiple myeloma
High molecular response rate of polycythemia vera patients treated with pegylated interferon α–2a
Serial transplantation of mismatched donor hematopoietic cells between HLA-identical sibling pairs with congenital immunodeficiency: in vivo tolerance permits rapid immune reconstitution following T-replete transplantation without GVHD in the secondary recipient
Autologous graft-versus-host disease–like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia
Issue Archive
September 15 2006
In this Issue
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation
Clinical Trials & Observations
Persis J. Amrolia,Giada Muccioli-Casadei,Helen Huls,Stuart Adams,April Durett,Adrian Gee,Eric Yvon,Heidi Weiss,Mark Cobbold,H. Bobby Gaspar,Cliona Rooney,Ingrid Kuehnle,Victor Ghetie,John Schindler,Robert Krance,Helen E. Heslop,Paul Veys,Ellen Vitetta,Malcolm K. Brenner
REVIEW ARTICLES
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Clinical Trials & Observations
Michele Baccarani,Giuseppe Saglio,John Goldman,Andreas Hochhaus,Bengt Simonsson,Frederick Appelbaum,Jane Apperley,Francisco Cervantes,Jorge Cortes,Michael Deininger,Alois Gratwohl,François Guilhot,Mary Horowitz,Timothy Hughes,Hagop Kantarjian,Richard Larson,Dietger Niederwieser,Richard Silver,Rudiger Hehlmann
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
CLINICAL TRIALS AND OBSERVATIONS
Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers
Clinical Trials & Observations
Richard B. Stead,John Lambert,Dawie Wessels,Julie S. Iwashita,Kerstin K. Leuther,Kathryn W. Woodburn,Peter J. Schatz,Douglas M. Okamoto,Robert Naso,Anne-Marie Duliege
Survival benefit with imatinib mesylate versus interferon-α–based regimens in newly diagnosed chronic-phase chronic myelogenous leukemia
Clinical Trials & Observations
Hagop M. Kantarjian,Moshe Talpaz,Susan O'Brien,Daniel Jones,Francis Giles,Guillermo Garcia-Manero,Stefan Faderl,Farhad Ravandi,Mary Beth Rios,Jianqin Shan,Jorge Cortes
ERRATA
GENE THERAPY
HEMATOPOIESIS
The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera
Clinical Trials & Observations
Brief Report
Eric Lippert,Marjorie Boissinot,Robert Kralovics,François Girodon,Irène Dobo,Vincent Praloran,Nathalie Boiret-Dupré,Radek C. Skoda,Sylvie Hermouet
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Human complement receptor type 1–directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis
Sergei Zaitsev,Kristina Danielyan,Juan-Carlos Murciano,Kumkum Ganguly,Tatiana Krasik,Ronald P. Taylor,Steven Pincus,Steven Jones,Douglas B. Cines,Vladimir R. Muzykantov
A novel fibrinogen variant (fibrinogen Seoul II; AαGln328Pro) characterized by impaired fibrin α-chain cross-linking
Clinical Trials & Observations
Compound heterozygosity of novel missense mutations in the gamma-glutamyl-carboxylase gene causes hereditary combined vitamin K–dependent coagulation factor deficiency
Clinical Trials & Observations
Dhouha Darghouth,Kevin W. Hallgren,Rebecca L. Shtofman,Amel Mrad,Youssef Gharbi,Ahmed Maherzi,Radhia Kastally,Sophie LeRicousse,Kathleen L. Berkner,Jean-Philippe Rosa
IMMUNOBIOLOGY
Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS)
David T. Teachey,Dana A. Obzut,Kelly Axsom,John K. Choi,Kelly C. Goldsmith,Junior Hall,Jessica Hulitt,Catherine S. Manno,John M. Maris,Nicholas Rhodin,Kathleen E. Sullivan,Valerie I. Brown,Stephan A. Grupp
Frequent antibody production against RARα in both APL mice and patients
Brief Report
Marie Robin,Juliette Andreu-Gallien,Marie-Helene Schlageter,Djaouida Bengoufa,Isabelle Guillemot,Katerina Pokorna,Carine Robert,Jerome Larghero,Philippe Rousselot,Emmanuel Raffoux,Herve Dombret,Pierre Fenaux,Marika Pla,Dominique Charron,Rose-Ann Padua,Christine Chomienne
NEOPLASIA
Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols
Clinical Trials & Observations
Amy Holleman,Monique L. den Boer,Meyling H. Cheok,Karin M. Kazemier,Deqing Pei,James R. Downing,Gritta E. Janka-Schaub,Ulrich Göbel,Ulrike B. Graubner,Ching-Hon Pui,William E. Evans,Rob Pieters
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia
Clinical Trials & Observations
Brunangelo Falini,Maria Paola Martelli,Niccolò Bolli,Rossella Bonasso,Emanuela Ghia,Maria Teresa Pallotta,Daniela Diverio,Ildo Nicoletti,Roberta Pacini,Alessia Tabarrini,Barbara Verducci Galletti,Roberta Mannucci,Giovanni Roti,Roberto Rosati,Giorgina Specchia,Arcangelo Liso,Enrico Tiacci,Myriam Alcalay,Lucilla Luzi,Sara Volorio,Loris Bernard,Anna Guarini,Sergio Amadori,Franco Mandelli,Fabrizio Pane,Francesco Lo-Coco,Giuseppe Saglio,Pier-Giuseppe Pelicci,Massimo F. Martelli,Cristina Mecucci,for the GIMEMA Acute Leukemia Working Party
The molecular classification of multiple myeloma
Clinical Trials & Observations
Fenghuang Zhan,Yongsheng Huang,Simona Colla,James P. Stewart,Ichiro Hanamura,Sushil Gupta,Joshua Epstein,Shmuel Yaccoby,Jeffrey Sawyer,Bart Burington,Elias Anaissie,Klaus Hollmig,Mauricio Pineda-Roman,Guido Tricot,Frits van Rhee,Ronald Walker,Maurizio Zangari,John Crowley,Bart Barlogie,John D. Shaughnessy, Jr
NPM-ALK–dependent expression of the transcription factor CCAAT/enhancer binding protein β in ALK-positive anaplastic large cell lymphoma
Leticia Quintanilla-Martinez,Stefania Pittaluga,Cornelius Miething,Margit Klier,Martina Rudelius,Theresa Davies-Hill,Natasa Anastasov,Antonio Martinez,Angelica Vivero,Justus Duyster,Elaine S. Jaffe,Falko Fend,Mark Raffeld
High molecular response rate of polycythemia vera patients treated with pegylated interferon α–2a
Clinical Trials & Observations
Brief Report
Jean-Jacques Kiladjian,Bruno Cassinat,Pascal Turlure,Nathalie Cambier,Murielle Roussel,Sylvia Bellucci,Marie-Laurence Menot,Gerald Massonnet,Jean-Luc Dutel,Kamel Ghomari,Philippe Rousselot,Marie-Jose Grange,Yasmina Chait,William Vainchenker,Nathalie Parquet,Lina Abdelkader-Aljassem,Jean-François Bernard,Jean-Didier Rain,Sylvie Chevret,Christine Chomienne,Pierre Fenaux
PHAGOCYTES
RED CELLS
STEM CELLS IN HEMATOLOGY
TRANSPLANTATION
Serial transplantation of mismatched donor hematopoietic cells between HLA-identical sibling pairs with congenital immunodeficiency: in vivo tolerance permits rapid immune reconstitution following T-replete transplantation without GVHD in the secondary recipient
Clinical Trials & Observations
Brief Report
Jonathan M. Cohen,Valerie Rogers,H. Bobby Gaspar,Alison Jones,E. Graham Davies,Kanchan Rao,Daniel J. McCloskey,Kimberley Gilmour,Robert Wynn,Persis J. Amrolia,Paul Veys
Autologous graft-versus-host disease–like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia
Brief Report
Thorsten Zenz,Matthias Ritgen,Peter Dreger,Alexander Kröber,Thomas F. Barth,Richard Schlenk,Sebastian Böttcher,Michael J. Hallek,Michael Kneba,Donald Bunjes,Hartmut Döhner,Stephan Stilgenbauer
CORRESPONDENCE
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals